Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

NIH scrutinizes drug-company payments at Baylor

Nature (2010)Cite this article

Subjects

Funding agency raises 'serious concerns' about conflicts of interest.

Researchers at Baylor College of Medicine in Houston, Texas, are facing increased scrutiny of their grants by the US National Institutes of Health (NIH) following revelations that the university was not complying with the agency's financial conflict-of-interest policy.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Brendan Borrell
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Nature Medicine: Conflict of interest rules seen by some as too stringent

Related external links

NIH conflict-of-interest policy

Senator Charles Grassley's web page

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Borrell, B. NIH scrutinizes drug-company payments at Baylor. Nature (2010). https://doi.org/10.1038/news.2010.17

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.17

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research